Ethyl 6-bromo-2-chloro-1,8-naphthyridine-3-carboxylate

Catalog No.: 
ACBNEB905
CAS No.: 
1330583-62-4
Molecular Formula: 
C11H8BrClN2O2
Molecular Weight: 
315.55
Ethyl 6-bromo-2-chloro-1,8-naphthyridine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg97%$378.00InquiryInquiry
250mg97%$641.00InquiryInquiry
1g97%$841.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 6-bromo-2-chloro-1,8-naphthyridine-3-carboxylate
IUPAC Nameethyl 6-bromo-2-chloro-1,8-naphthyridine-3-carboxylate
MDL No.MFCD19982791
Molecular FormulaC11H8BrClN2O2
Molecular Weight315.55
SMILESO=C(C1=CC2=CC(Br)=CN=C2N=C1Cl)OCC
InChI KeyYBJKOMHKVBMRIF-UHFFFAOYSA-N
SynonymEthyl 6-bromo-2-chloro-1,8-naphthyridine-3-carboxylate;1,8-Naphthyridine-3-carboxylic acid, 6-bromo-2-chloro-, ethyl ester
CAS No.1330583-62-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBNEB905 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMWAR230 route compound structure diagram
    ACMWAR230206997-15-1In Stock
  4. Then
  5. ACBNEB905 route product structure diagram
    ACBNEB9051330583-62-4
Inquiry

2. ACBNEB905 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBNEB905 route product structure diagram
    ACBNEB9051330583-62-4
Inquiry

3. ACBNEB905 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBNEB905 route product structure diagram
    ACBNEB9051330583-62-4
Inquiry

Comments (0)